byiShook Opinion
Feb 11, 2025 - 17:30
Edwards Lifesciences stock rose slightly late Tuesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat. The post Edwards Pops On Fourth-Quarter Beat As Heart-Valve Replacements Top $1 Billion appeared first on Investor's Business Daily.
Edwards Lifesciences stock rose slightly late Tuesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.
The post Edwards Pops On Fourth-Quarter Beat As Heart-Valve Replacements Top $1 Billion appeared first on Investor's Business Daily.